News from insmed incorporated A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 13, 2012, 08:00 ET

Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies...

Nov 13, 2012, 08:00 ET

Insmed Announces CLEAR-108 Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections Has Completed Target Enrollment

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Nov 12, 2012, 08:00 ET

Insmed To Present At Two Upcoming Investor Conferences

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Nov 07, 2012, 07:15 ET

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...

Nov 07, 2012, 07:00 ET

Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Oct 24, 2012, 08:00 ET

Insmed to Host 2012 Third Quarter Earnings Conference Call

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering...

Sep 28, 2012, 08:23 ET

Insmed Announces Pricing of Approximately $26 Million Direct Public Offering

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering...

Sep 11, 2012, 08:00 ET

Insmed Appoints Will Lewis as President and Chief Executive Officer

 Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering...

Aug 30, 2012, 08:00 ET

Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...

Aug 14, 2012, 08:00 ET

Insmed to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...

Aug 07, 2012, 07:00 ET

Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...

Aug 06, 2012, 08:00 ET

Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Aug 02, 2012, 08:00 ET

Insmed Receives Second Composition Of Matter Patent For ARIKACE®

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Jul 30, 2012, 08:00 ET

Insmed Announces Planned Departure Of Chief Financial Officer

MONMOUTH JUNCTION, N.J., July 30, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on...

Jul 24, 2012, 08:00 ET

Insmed to Host 2012 Second Quarter Earnings Conference Call

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the lung,...

Jul 10, 2012, 08:00 ET

Insmed To Present At JMP Securities 7th Annual Healthcare Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Jul 02, 2012, 08:00 ET

Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Jun 27, 2012, 08:00 ET

Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycobacteria (NTM) Lung Disease

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the first patient has been dosed in the Company's...

May 30, 2012, 08:00 ET

Insmed Provides Corporate Update

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today provided a corporate update, including the Company's current...

May 23, 2012, 08:00 ET

Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that it has begun screening patients for its U.S. phase 2...